Anti-Cancer Activities and Interaction of Imiquimod and Flex-Het, SHetA2, in Melanoma and Ovarian Cancer

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"Anti-Cancer Activities and Interaction of Imiquimod and Flex-Het, SHetA2, in Melanoma and Ovarian Cancer"
written by Mark F. Naylor, David M. Thompson, Stan Lightfoot, Doris Mangiaracina Benbrook,
published by Journal of Cancer Therapy, Vol.4 No.6A, 2013

has been cited by the following article(s):

[1]	Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing
	The AAPS Journal, 2023

[2]	Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780
	2019

[3]	Optimization of a vaginal suppository formulation to deliver SHetA2 as a novel treatment for cervical dysplasia
	2018

[4]	SHetA2 interference with mortalin binding to p66shc and p53 identified using drug-conjugated magnetic microspheres
	Investigational new …, 2014

[1]	Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing The AAPS Journal, 2023 DOI:10.1208/s12248-023-00874-7

[2]	Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780 European Journal of Medicinal Chemistry, 2019 DOI:10.1016/j.ejmech.2019.03.010

[3]	SHetA2 interference with mortalin binding to p66shc and p53 identified using drug-conjugated magnetic microspheres Investigational New Drugs, 2014 DOI:10.1007/s10637-013-0041-x

Top